메뉴 건너뛰기




Volumn 13, Issue 3, 1994, Pages 455-458

Clinical experience with etidronate in osteoporosis

Author keywords

Bisphophanate; Bone Density; Fracture; Menopause

Indexed keywords

ETIDRONIC ACID;

EID: 0027965994     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/BF02242942     Document Type: Article
Times cited : (12)

References (14)
  • 1
    • 0025366467 scopus 로고
    • Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis
    • (1990) N E J M , vol.322 , pp. 1265-1271
    • Storm, T.1    Thaborg, G.2    Steiniche, T.3
  • 7
    • 84936418694 scopus 로고    scopus 로고
    • Dambacher, M.A., Neff, M., Schmitt, S., Ruegsegger, P. Etidronate in slow and fast bone loser osteoporotic patients. Hong Kong 4th International Symposium on Osteoporosis. 1993 (Abs. no 424).
  • 8
    • 0026530921 scopus 로고
    • Cyclic oral phosphate and etidronate increase femoral and lumbar bone mineral density and reduce lumbar spine fracture rate over three years
    • (1992) J Nucl Med , vol.33 , pp. 1-5
    • Silberstein, E.B.1    Schnur, W.2
  • 9
    • 84936392906 scopus 로고    scopus 로고
    • Gold, A., Tenenhouse, A. A comparison of cyclical etidronate alone or combined with sodium fluoride in the treatment of osteoporosis. Hong Kong 4th International symposium on Osteoporosis. 1993, (Abs. no 467).
  • 11
    • 84936440553 scopus 로고    scopus 로고
    • Walters, B.G., Lilley, J., Heath, D.A. The use of didronel/calcium to prevent postmenopausal bone loss. Bone and Mineral 1992, Supp vol 17, S25 (Abs.).
  • 13


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.